Lexicon Pharmaceuticals, Inc. has grown revenue 367% a year over three years and 42% a year over five. Revenue growth, 3-year annual rate: +367% (Biotechnology median +17%). Revenue growth, 5-year rate: +42%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

LXRXLexicon Pharmaceuticals, Inc.

Healthcare

$1.67+40% 1Y

$1.67

$1.1452 weeks$2.50

Is it growing?

Mixed

Neither accelerating nor breaking down: operating margin widening (+397.4 points), but revenue shrinking (−29% year on year).

1 good, 1 to watch, 1 without data

Revenue trend−29% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +42% a year.

Margin direction+397.4 points operating

Trailing-twelve-month operating margin, -1048.7% now against -1446.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LXRX growing?

Lexicon Pharmaceuticals, Inc. has grown revenue 367% a year over three years and 42% a year over five.

+367%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +42%
Revenue growth, 5-year rate · +367% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›